STAT+: Early update shows Wave’s RNA drug cut visceral fat

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! With STAT reporting from ASH this year, we have some stories in the blood space. Also, a potential Dupixent competitor is in the works, and we examine the fallout from Friday’s ACIP meeting. […]

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

Quick Read Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed guidance for 7.5-8.0% organic growth. Eli Lilly (LLY) posted 54% revenue growth driven by Mounjaro ($6.52B) and Zepbound ($3.57B). Lilly raised guidance to $63.0-63.5B revenue. Lilly’s operating margin reached 48.3% versus Abbott’s 19.4%. Lilly trades at 49.5x P/E […]

Should I scoop up some Magnum Ice Cream shares for my ISA? 

Shares of The Magnum Ice Cream Company (LSE:MICC) started trading today (8 December), making them eligible for an ISA portfolio.  This came after the ice cream business was demerged from Unilever over the weekend. Unilever shareholders will receive one Magnum share for every five Unilever shares they own.  However, I’m not a Unilever shareholder. So, […]

Magnum ice cream valued at US$9.2bil in Amsterdam listing

Magnum, which will command more than a fifth of the US$87 billion global ice cream market, is betting on the allure of indulgent snacks. (EPA Images pic) LONDON: Magnum Ice Cream Company traded at €12.96 per share in its Amsterdam debut today, implying a market capitalisation of €7.93 billion (US$9.24 billion), as it finalised a […]